{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:32:54Z","timestamp":1786368774633,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S035591\/1"],"award-info":[{"award-number":["MR\/S035591\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000659","name":"DH | NIHR | Research Trainees Coordinating Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["216430\/Z\/19\/Z"],"award-info":[{"award-number":["216430\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cognitive impairment is a common but under-treated feature of Major Depressive Disorder (MDD). Preclinical and early human studies suggest that 5-HT\n                    <jats:sub>4<\/jats:sub>\n                    receptor (5-HT\n                    <jats:sub>4<\/jats:sub>\n                    R) agonists rapidly improve learning and memory, consistent with this receptor\u2019s role in hippocampal neuroplasticity. However, their effects in clinically depressed patients, remain unexplored. In this double-blind, randomised experimental medicine study, 52 right-handed, unmedicated individuals with MDD received 6\u20139 days of the 5-HT\n                    <jats:sub>4<\/jats:sub>\n                    R agonist PF-04995274 (15\u2009mg, once daily) or placebo. Participants subsequently underwent fMRI scanning during a memory encoding task and completed behavioural measures of auditory verbal learning and spatial working memory. Compared to placebo, PF-04995274 significantly increased activity in the hippocampus (ROI analysis) in response to novel versus familiar images, particularly in the left hemisphere. Whole brain analysis also revealed greater activation in the left inferior parietal lobule, a key region for memory processing. In contrast with previous studies using the 5-HT\n                    <jats:sub>4<\/jats:sub>\n                    R agonist prucalopride, PF-04995274 had notably limited effects on behavioural measures of memory. The results demonstrate that short term 5-HT\n                    <jats:sub>4<\/jats:sub>\n                    R agonism enhances hippocampal and parietal activity during memory encoding in patients with depression. This replicates and extends previous findings in healthy volunteers using prucalopride, and is consistent with preclinical evidence establishing a key role for 5-HT\n                    <jats:sub>4<\/jats:sub>\n                    Rs in hippocampal-dependent learning and memory. This translational evidence supports a role for 5-HT\n                    <jats:sub>4<\/jats:sub>\n                    R activation in modulating memory-related brain circuits in MDD and previously identified beneficial effects of another 5-HT4 receptor agonist, prucalopride, on cognitive performance.\n                  <\/jats:p>","DOI":"10.1038\/s41398-026-04141-z","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:54:26Z","timestamp":1781733266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects on hippocampal activity following novel 5-HT4 receptor agonism in unmedicated patients with depression: the RESTAND study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7848-1295","authenticated-orcid":false,"given":"Angharad N.","family":"de Cates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4640-699X","authenticated-orcid":false,"given":"Amy L.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5661-7921","authenticated-orcid":false,"given":"Jessica","family":"Scaife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-1327","authenticated-orcid":false,"given":"Marieke A. G.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5973-3765","authenticated-orcid":false,"given":"Beata R.","family":"Godlewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anutra","family":"Guru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5518-6138","authenticated-orcid":false,"given":"Philip J.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1609-8335","authenticated-orcid":false,"given":"Catherine J.","family":"Harmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susannah E.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"4141_CR1","unstructured":"Depression. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/depression, 2023."},{"key":"4141_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41398-022-02249-6","volume":"12","author":"MJ Colwell","year":"2022","unstructured":"Colwell MJ, Tagomori H, Chapman S, Gillespie AL, Cowen PJ, Harmer CJ, et al. Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research. Trans Psychiatry. 2022;12:484.","journal-title":"Trans Psychiatry"},{"key":"4141_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1017\/S0033291710001911","volume":"41","author":"HJ Conradi","year":"2011","unstructured":"Conradi HJ, Ormel J, de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011;41:1165\u201374.","journal-title":"Psychol Med"},{"key":"4141_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/JCP.0b013e31820ebd2c","volume":"31","author":"SM McClintock","year":"2011","unstructured":"McClintock SM, Husain MM, Wisniewski SR, Nierenberg AA, Stewart JW, Trivedi MH, et al. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol. 2011;31:180\u20136.","journal-title":"J Clin Psychopharmacol"},{"key":"4141_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2019.152147","volume":"97","author":"MJ Knight","year":"2020","unstructured":"Knight MJ, Lyrtzis E, Baune BT. The association of cognitive deficits with mental and physical Quality of Life in Major Depressive Disorder. Compr Psychiatry. 2020;97:152147.","journal-title":"Compr Psychiatry"},{"key":"4141_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/YCO.0000000000000378","volume":"31","author":"MJ Knight","year":"2018","unstructured":"Knight MJ, Baune BT. Cognitive dysfunction in major depressive disorder. Curr Opin Psychiatry. 2018;31:26\u201331.","journal-title":"Curr Opin Psychiatry"},{"key":"4141_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/cne.20447","volume":"484","author":"MT Vilar\u00f3","year":"2005","unstructured":"Vilar\u00f3 MT, Cort\u00e9s R, Mengod G. Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions. J Comp Neurol. 2005;484:418\u201339.","journal-title":"J Comp Neurol"},{"key":"4141_CR8","first-page":"120","volume":"37","author":"V Beliveau","year":"2017","unstructured":"Beliveau V, Ganz M, Feng L, Ozenne B, H\u00f8jgaard L, Fisher PM, et al. A high-resolution in vivo atlas of the human brain\u2019s serotonin system. J Neurosci. 2017;37:120\u20138.","journal-title":"J Neurosci"},{"key":"4141_CR9","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1111\/j.1460-9568.1996.tb01553.x","volume":"8","author":"V Compan","year":"1996","unstructured":"Compan V, Daszuta A, Salin P, Sebben M, Bockaert J, Dumuis A. Lesion study of the distribution of serotonin 5-HT4 receptors in rat basal ganglia and hippocampus. Eur J Neurosci. 1996;8:2591\u20138.","journal-title":"Eur J Neurosci"},{"key":"4141_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.nlm.2016.06.014","volume":"138","author":"H Hagena","year":"2017","unstructured":"Hagena H, Manahan-Vaughan D. The serotonergic 5-HT4 receptor: A unique modulator of hippocampal synaptic information processing and cognition. Neurobiol Learn Mem. 2017;138:145\u201353.","journal-title":"Neurobiol Learn Mem"},{"key":"4141_CR11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.tips.2008.07.001","volume":"29","author":"MV King","year":"2008","unstructured":"King MV, Marsden CA, Fone KC. A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci. 2008;29:482\u201392.","journal-title":"Trends Pharmacol Sci"},{"key":"4141_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0028-3908(01)00123-X","volume":"41","author":"L Lamirault","year":"2001","unstructured":"Lamirault L, Simon H. Enhancement of place and object recognition memory in young adult and old rats by RS 67333, a partial agonist of 5-HT4 receptors. Neuropharmacology. 2001;41:844\u201353.","journal-title":"Neuropharmacology"},{"key":"4141_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0028-3908(97)00055-5","volume":"36","author":"DJ Fontana","year":"1997","unstructured":"Fontana DJ, Daniels SE, Wong EH, Clark RD, Eglen RM. The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation. Neuropharmacology. 1997;36:689\u201396.","journal-title":"Neuropharmacology"},{"key":"4141_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.brainres.2011.06.020","volume":"1405","author":"E Marchetti","year":"2011","unstructured":"Marchetti E, Jacquet M, Escoffier G, Miglioratti M, Dumuis A, Bockaert J, et al. Enhancement of reference memory in aged rats by specific activation of 5-HT(4) receptors using an olfactory associative discrimination task. Brain Res. 2011;1405:49\u201356.","journal-title":"Brain Res"},{"key":"4141_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.neulet.2016.01.055","volume":"616","author":"F Darcet","year":"2016","unstructured":"Darcet F, Gardier AM, David DJ, Guilloux JP. Chronic 5-HT4 receptor agonist treatment restores learning and memory deficits in a neuroendocrine mouse model of anxiety\/depression. Neurosci Lett. 2016;616:197\u2013203.","journal-title":"Neurosci Lett"},{"key":"4141_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.brainres.2016.11.021","volume":"1655","author":"N Kozono","year":"2017","unstructured":"Kozono N, Ohtani A, Shiga T. Roles of the serotonin 5-HT4 receptor in dendrite formation of the rat hippocampal neurons in vitro. Brain Res. 2017;1655:114\u201321.","journal-title":"Brain Res"},{"key":"4141_CR17","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.biopsych.2004.12.023","volume":"57","author":"G Lucas","year":"2005","unstructured":"Lucas G, Compan V, Charnay Y, Neve RL, Nestler EJ, Bockaert J, et al. Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists. Biol Psychiatry. 2005;57:918\u201325.","journal-title":"Biol Psychiatry"},{"key":"4141_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/00001756-199902250-00019","volume":"10","author":"A Siniscalchi","year":"1999","unstructured":"Siniscalchi A, Badini I, Beani L, Bianchi C. 5-HT4 receptor modulation of acetylcholine outflow in guinea pig brain slices. Neuroreport. 1999;10:547\u201351.","journal-title":"Neuroreport"},{"key":"4141_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41386-019-0540-3","volume":"45","author":"BK Chen","year":"2020","unstructured":"Chen BK, Mendez-David I, Luna VM, Faye C, Gardier AM, David DJ, et al. Prophylactic efficacy of 5-HT agonists against stress. Neuropsychopharmacology. 2020;45:542\u201352.","journal-title":"Neuropsychopharmacology"},{"key":"4141_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","volume":"55","author":"G Lucas","year":"2007","unstructured":"Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S, et al. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron. 2007;55:712\u201325.","journal-title":"Neuron"},{"key":"4141_CR21","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1017\/S0033291719002836","volume":"50","author":"SE Murphy","year":"2020","unstructured":"Murphy SE, Wright L, Browning M, Cowen P, Harmer C. A role for 5-HT4 receptors in human learning and memory. Psychol Med. 2020;50:2722\u201330.","journal-title":"Psychol Med"},{"key":"4141_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41398-021-01568-4","volume":"11","author":"AN de Cates","year":"2021","unstructured":"de Cates AN, Wright LC, Martens MAG, Gibson D, Turkmen C, Cowen PJ, et al. Deja-vu? Neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task. Trans Psychiatry. 2021;11:497.","journal-title":"Trans Psychiatry"},{"key":"4141_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.859123","volume":"13","author":"AN de Cates","year":"2022","unstructured":"de Cates AN, Martens MAG, Wright LC, Gould van Praag CD, Capitao LP, Cowen PJ, et al. The effect of the 5-HT4 agonist, prucalopride, on an fMRI faces task in the healthy human brain. Front Psychiatry. 2022;13:859123.","journal-title":"Front Psychiatry"},{"key":"4141_CR24","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1017\/S0033291719002836","volume":"50","author":"S Murphy","year":"2020","unstructured":"Murphy S, Wright L, Browning M, Cowen P, Harmer C. A role for 5-HT4 receptors in human learning and memory. Psychol Med. 2020;50:2722\u201330.","journal-title":"Psychol Med"},{"key":"4141_CR25","unstructured":"Pfizer. Investigator\u2019s Brochure PF-04995274: Pfizer; 2011."},{"key":"4141_CR26","doi-asserted-by":"publisher","unstructured":"Gillespie AL, de Cates AN, Scaife J, Blandhol M, Martens MAG, Gibson D, Godlewska BR, et al. Early effects of a novel 5-HT4 agonist (PF-04995274) and the SSRI citalopram on emotional cognition in unmedicated depression: the RESTAND study. British J Psychiatry 2026:1\u201310 https:\/\/doi.org\/10.1192\/bjp.2026.10664.","DOI":"10.1192\/bjp.2026.10664"},{"key":"4141_CR27","unstructured":"Pfizer. A Phase I, healthy volunteer determination of 5HT4 receptor occupancy of PF-04995274, using PET with Ligand [11C]PF-051274012011."},{"key":"4141_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1192\/bjp.167.1.99","volume":"167","author":"RP Snaith","year":"1995","unstructured":"Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995;167:99\u2013103.","journal-title":"Br J Psychiatry"},{"key":"4141_CR29","volume-title":"Manual for the State-Trait Anxiety Inventory","author":"C Spielberger","year":"1983","unstructured":"Spielberger C, Gorssuch R, Lushene P, Vagg P, Jacobs G Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, Inc; 1983."},{"key":"4141_CR30","volume-title":"Manual of the Eysenck Personality Questionnaire (Junior and Adult)","author":"H Eysenck","year":"1975","unstructured":"Eysenck H, Eysenck S Manual of the Eysenck Personality Questionnaire (Junior and Adult). Kent, UK: Hodder & Stoughton;1975."},{"key":"4141_CR31","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","volume":"54","author":"D Watson","year":"1988","unstructured":"Watson D, Clark L, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scale. J Pers Soc Psychol. 1988;54:1063\u201370.","journal-title":"J Pers Soc Psychol"},{"key":"4141_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","volume":"47","author":"A Bond","year":"1974","unstructured":"Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Med Psychol. 1974;47:211\u20138.","journal-title":"Br J Med Psychol"},{"key":"4141_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5056\/jnm16004","volume":"22","author":"MS Sajid","year":"2016","unstructured":"Sajid MS, Hebbar M, Baig MK, Li A, Philipose Z. Use of prucalopride for chronic constipation: a systematic review and meta-analysis of published randomized, controlled trials. J Neurogastroenterol Motil. 2016;22:412\u201322.","journal-title":"J Neurogastroenterol Motil"},{"key":"4141_CR34","volume-title":"Manual for the Beck Depression Inventory-II","author":"A Beck","year":"1996","unstructured":"Beck A, Steer R, Brown G Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996."},{"key":"4141_CR35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/0361073X.2023.2172949","volume":"50","author":"Y Jia","year":"2024","unstructured":"Jia Y, Woltering S, Deutz NEP, Engelen MPKJ, Coyle KS, Maio MR, et al. Working memory precision and associative binding in mild cognitive impairment. Exp Aging Res. 2024;50:206\u201324.","journal-title":"Exp Aging Res"},{"key":"4141_CR36","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1073\/pnas.0811879106","volume":"106","author":"N Filippini","year":"2009","unstructured":"Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci USA. 2009;106:7209\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4141_CR37","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.neuroimage.2011.11.063","volume":"59","author":"N Filippini","year":"2012","unstructured":"Filippini N, Nickerson LD, Beckmann CF, Ebmeier KP, Frisoni GB, Matthews PM, et al. Age-related adaptations of brain function during a memory task are also present at rest. Neuroimage. 2012;59:3821\u20138.","journal-title":"Neuroimage"},{"key":"4141_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrn2335","volume":"9","author":"CM Bird","year":"2008","unstructured":"Bird CM, Burgess N. The hippocampus and memory: insights from spatial processing. Nat Rev Neurosci. 2008;9:182\u201394.","journal-title":"Nat Rev Neurosci"},{"key":"4141_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1073858412440596","volume":"19","author":"ML Seghier","year":"2013","unstructured":"Seghier ML. The angular gyrus: multiple functions and multiple subdivisions. Neuroscientist. 2013;19:43\u201361.","journal-title":"Neuroscientist"},{"key":"4141_CR40","doi-asserted-by":"publisher","first-page":"9474","DOI":"10.1523\/JNEUROSCI.3603-16.2017","volume":"37","author":"M van der Linden","year":"2017","unstructured":"van der Linden M, Berkers RMWJ, Morris RGM, Fern\u00e1ndez G. Angular gyrus involvement at encoding and retrieval is associated with durable but less specific memories. J Neurosci. 2017;37:9474\u201385.","journal-title":"J Neurosci"},{"key":"4141_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fncel.2017.00305","volume":"11","author":"B Liu","year":"2017","unstructured":"Liu B, Liu J, Wang M, Zhang Y, Li L. From serotonin to neuroplasticity: evolvement of theories for major depressive disorder. Front Cell Neurosci. 2017;11:305.","journal-title":"Front Cell Neurosci"},{"key":"4141_CR42","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41380-019-0615-x","volume":"25","author":"RB Price","year":"2020","unstructured":"Price RB, Duman R. Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Mol Psychiatry. 2020;25:530\u201343.","journal-title":"Mol Psychiatry"},{"key":"4141_CR43","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.biopsych.2019.01.011","volume":"85","author":"YI Sheline","year":"2019","unstructured":"Sheline YI, Liston C, McEwen BS. Parsing the hippocampus in depression: chronic stress, hippocampal volume, and major depressive disorder. Biol Psychiatry. 2019;85:436\u20138.","journal-title":"Biol Psychiatry"},{"key":"4141_CR44","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.biopsych.2018.09.031","volume":"85","author":"EL Belleau","year":"2019","unstructured":"Belleau EL, Treadway MT, Pizzagalli DA. The impact of stress and major depressive disorder on hippocampal and medial prefrontal cortex morphology. Biol Psychiatry. 2019;85:443\u201353.","journal-title":"Biol Psychiatry"},{"key":"4141_CR45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jad.2012.03.002","volume":"141","author":"X Cao","year":"2012","unstructured":"Cao X, Liu Z, Xu C, Li J, Gao Q, Sun N, et al. Disrupted resting-state functional connectivity of the hippocampus in medication-na\u00efve patients with major depressive disorder. J Affect Disord. 2012;141:194\u2013203.","journal-title":"J Affect Disord"},{"key":"4141_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02490-7","volume":"20","author":"ZY Hao","year":"2020","unstructured":"Hao ZY, Zhong Y, Ma ZJ, Xu HZ, Kong JY, Wu Z, et al. Abnormal resting-state functional connectivity of hippocampal subfields in patients with major depressive disorder. BMC Psychiatry. 2020;20:71.","journal-title":"BMC Psychiatry"},{"key":"4141_CR47","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.biopsych.2007.12.015","volume":"63","author":"JP Hamilton","year":"2008","unstructured":"Hamilton JP, Gotlib IH. Neural substrates of increased memory sensitivity for negative stimuli in major depression. Biol Psychiatry. 2008;63:1155\u201362.","journal-title":"Biol Psychiatry"},{"key":"4141_CR48","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1001\/jamapsychiatry.2014.1087","volume":"71","author":"KR Cullen","year":"2014","unstructured":"Cullen KR, Westlund MK, Klimes-Dougan B, Mueller BA, Houri A, Eberly LE, et al. Abnormal amygdala resting-state functional connectivity in adolescent depression. JAMA Psychiatry. 2014;71:1138\u201347.","journal-title":"JAMA Psychiatry"},{"key":"4141_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.55","volume":"6","author":"WK Lau","year":"2016","unstructured":"Lau WK, Leung MK, Lee TM, Law AC. Resting-state abnormalities in amnestic mild cognitive impairment: a meta-analysis. Transl Psychiatry. 2016;6:e790.","journal-title":"Transl Psychiatry"},{"key":"4141_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mri.2011.07.007","volume":"30","author":"M Jin","year":"2012","unstructured":"Jin M, Pelak VS, Cordes D. Aberrant default mode network in subjects with amnestic mild cognitive impairment using resting-state functional MRI. Magn Reson Imaging. 2012;30:48\u201361.","journal-title":"Magn Reson Imaging"},{"key":"4141_CR51","doi-asserted-by":"publisher","first-page":"e63591","DOI":"10.7554\/eLife.63591","volume":"10","author":"O Numssen","year":"2021","unstructured":"Numssen O, Bzdok D, Hartwigsen G. Functional specialization within the inferior parietal lobes across cognitive domains. eLife. 2021;10:e63591.","journal-title":"eLife"},{"key":"4141_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1196\/annals.1440.006","volume":"1124","author":"MA Lambon Ralph","year":"2008","unstructured":"Lambon Ralph MA, Patterson K. Generalization and differentiation in semantic memory: insights from semantic dementia. Ann N Y Acad Sci. 2008;1124:61\u201376.","journal-title":"Ann N Y Acad Sci"},{"key":"4141_CR53","first-page":"1124","volume":"8","author":"AN de Cates","year":"2023","unstructured":"de Cates AN, Martens MAG, Wright LC, Gibson D, Spitz G, Gould van Praag CD, et al. 5-HT4 receptor agonist effects on functional connectivity in the human brain; Implications for pro-cognitive action. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023;8:1124\u201334.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"4141_CR54","doi-asserted-by":"publisher","unstructured":"de Cates AN, Hamilton S, Guru A, Blandhol M, Colwell M, Cowen PJ et al. Pro-cognitive effects of 5-HT4 receptor agonism in individuals with remitted depression. Medrxiv: 2025;332371, https:\/\/doi.org\/10.1017\/S0033291726104450.","DOI":"10.1017\/S0033291726104450"},{"key":"4141_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2982.2007.01059.x","volume":"20","author":"JH De Maeyer","year":"2008","unstructured":"De Maeyer JH, Lefebvre RA, Schuurkes JA. 5-HT4 receptor agonists: similar but not the same. Neurogastroenterol Motil. 2008;20:99\u2013112.","journal-title":"Neurogastroenterol Motil"},{"key":"4141_CR56","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1017\/S0033291720000938","volume":"51","author":"VH Dam","year":"2021","unstructured":"Dam VH, Stenb\u00e6k DS, K\u00f6hler-Forsberg K, Ip C, Ozenne B, Sahakian BJ, et al. Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study. Psychol Med. 2021;51:2347\u201356.","journal-title":"Psychol Med"},{"key":"4141_CR57","doi-asserted-by":"crossref","unstructured":"de Cates AN, Harmer CJ, Harrison PJ, Cowen PJ, Emmanuel A, Travis S, et al. Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial. Br J Psychiatry 2024: 1\u20138.","DOI":"10.1192\/bjp.2024.97"},{"key":"4141_CR58","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/acps.13211","volume":"142","author":"S Larsen","year":"2020","unstructured":"Larsen S, Kohler-Forsberg K, Dam V, Poulsen A, Svarer C, Jensen P, et al. Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women. Acta Psychiatr Scand. 2020;142:294\u2013306.","journal-title":"Acta Psychiatr Scand"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04141-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04141-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04141-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:02:59Z","timestamp":1786366979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04141-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4141"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04141-z","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the South Central Research Ethics Committee (18\/SC\/0076) and pre-registered with clinicaltrials.gov (NCT03516604). Participants provided written informed consent and all methods were performed in accordance with the relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"CJH has received consultancy fees from P1vital Ltd., Jannsen Pharmaceuticals, UCB, Compass Pathways, and Lundbeck. She is a co-director of TnC Psychiatry and Neuroscience. SEM has received consultancy fees from Zogenix, Sumitomo Dainippon Pharma, P1vital Ltd. and Johnson & Johnson Pharmaceuticals. CJH and SEM recently held grant income from Zogenix, UCB Pharma and Janssen Pharmaceuticals and ADM. CJH, SEM and PJC recently held grant income from a collaborative research project with Pfizer. ALG has received consultancy fees from Zogenix and Johnson & Johnson Pharmaceuticals. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"405"}}